This work underscores the efficacy of TNF‐α siRNA‐LNPs in treating lung inflammatory diseases like ALI and highlights the importance of optimizing LNP distribution and delivery timing to enhance therapeutic outcomes. Here, TNF is linked to acute respiratory distress syndrome.